J. He, Y. Zhang, T. Xu, Q. Zhao, D. Wang et al., Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke, JAMA, vol.311, issue.5, pp.479-489, 2014.
DOI : 10.1001/jama.2013.282543

M. Lee, B. Ovbiagele, K. Hong, Y. Wu, J. Lee et al., Effect of Blood Pressure Lowering in Early Ischemic Stroke, Stroke, vol.46, issue.7, pp.1883-1889, 2015.
DOI : 10.1161/STROKEAHA.115.009552

E. Sandset, P. Bath, G. Boysen, D. Jatuzis, J. Korv et al., The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial, The Lancet, vol.377, issue.9767, pp.741-750, 2011.
DOI : 10.1016/S0140-6736(11)60104-9

P. Bath, A. Houlton, L. Woodhouse, N. Sprigg, J. Wardlaw et al., Statistical Analysis Plan for the ???Efficacy of Nitric Oxide in Stroke??? (ENOS) Trial, International Journal of Stroke, vol.12, issue.3, pp.372-374, 2014.
DOI : 10.1161/STROKEAHA.111.641423

P. Bath, L. Woodhouse, P. Scutt, K. Krishnan, J. Wardlaw et al., Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial, Lancet, vol.385, issue.14, pp.617-628, 2015.

S. Ankolekar, M. Fuller, I. Cross, C. Renton, P. Cox et al., Feasibility of an Ambulance-Based Stroke Trial, and Safety of Glyceryl Trinitrate in Ultra-Acute Stroke: The Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824), Stroke, vol.44, issue.11, pp.3120-3128, 2013.
DOI : 10.1161/STROKEAHA.113.001301

T. Munzel, A. Daiber, and T. Gori, Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance, Circulation, vol.123, issue.19, pp.2132-2144, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.981407

D. Tsikas, J. Sandmann, P. Luessen, A. Savva, S. Rossa et al., S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol.1546, issue.2, pp.422-434, 2001.
DOI : 10.1016/S0167-4838(01)00166-2

N. Marozkina and B. Gaston, S-Nitrosylation signaling regulates cellular protein interactions, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1820, issue.6, pp.722-729, 2012.
DOI : 10.1016/j.bbagen.2011.06.017

T. Rassaf, P. Kleinbongard, M. Preik, A. Dejam, P. Gharini et al., Plasma Nitrosothiols Contribute to the Systemic Vasodilator Effects of Intravenously Applied NO: Experimental and Clinical Study on the Fate of NO in Human Blood, Circulation Research, vol.91, issue.6, pp.470-477, 2002.
DOI : 10.1161/01.RES.0000035038.41739.CB

M. Gordge and X. F. , S-nitrosothiols as selective antithrombotic agents - possible mechanisms, British Journal of Pharmacology, vol.294, issue.1, pp.1572-1580, 2010.
DOI : 10.1111/j.1476-5381.2010.00670.x

Z. Kaposzta, A. Clifton, J. Molloy, J. Martin, and H. Markus, S-Nitrosoglutathione Reduces Asymptomatic Embolization After Carotid Angioplasty, Circulation, vol.106, issue.24, pp.3057-3062, 2002.
DOI : 10.1161/01.CIR.0000041251.07332.28

M. Khan, T. Dhammu, H. Sakakima, A. Shunmugavel, A. Gilg et al., The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke, Journal of Neurochemistry, vol.22, issue.2, pp.86-97, 2012.
DOI : 10.1111/j.1471-4159.2012.07947.x

M. Khan, B. Sekhon, S. Giri, M. Jatana, A. Gilg et al., -Nitrosoglutathione Reduces Inflammation and Protects Brain against Focal Cerebral Ischemia in a Rat Model of Experimental Stroke, Journal of Cerebral Blood Flow & Metabolism, vol.71, issue.86, pp.177-192, 2005.
DOI : 10.1161/01.STR.31.7.1588

URL : https://hal.archives-ouvertes.fr/hal-00109339

H. Al-sa-'doni and A. Ferro, S-Nitrosothiols: a class of nitric oxide-donor drugs, Clinical Science, vol.98, issue.5, pp.507-520, 2000.
DOI : 10.1042/cs0980507

C. Gaucher, A. Boudier, F. Dahboul, M. Parent, and P. Leroy, S-nitrosation/Denitrosation in Cardiovascular Pathologies: Facts and Concepts for the Rational Design of S-nitrosothiols, Current Pharmaceutical Design, vol.19, issue.3, pp.458-472, 2013.
DOI : 10.2174/1381612811306030458

URL : https://hal.archives-ouvertes.fr/hal-01273168

M. Parent, A. Boudier, F. Dupuis, C. Nouvel, A. Sapin et al., Are in situ formulations the keys for the therapeutic future of S-nitrosothiols?, European Journal of Pharmaceutics and Biopharmaceutics, vol.85, issue.3, pp.640-649, 2013.
DOI : 10.1016/j.ejpb.2013.08.005

URL : https://hal.archives-ouvertes.fr/hal-01273175

M. Parent, C. Nouvel, M. Koerber, A. Sapin, P. Maincent et al., PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release, Journal of Controlled Release, vol.172, issue.1, pp.292-304, 2013.
DOI : 10.1016/j.jconrel.2013.08.024

URL : https://hal.archives-ouvertes.fr/hal-01273194

T. Ahmed, H. Ibrahim, A. Samy, A. Kaseem, M. Nutan et al., Biodegradable Injectable In Situ Implants and Microparticles for Sustained Release of Montelukast: In Vitro Release, Pharmacokinetics, and Stability, AAPS PharmSciTech, vol.15, issue.3, pp.772-780, 2014.
DOI : 10.1208/s12249-014-0101-3

H. Kranz and R. Bodmeier, Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles, European Journal of Pharmaceutical Sciences, vol.34, issue.2-3, pp.164-172, 2008.
DOI : 10.1016/j.ejps.2008.03.004

M. Parent, F. Dahboul, R. Schneider, I. Clarot, P. Maincent et al., A complete physicochemical identity card of S-nitrosoglutathione, Curr Pharm Anal, vol.9, pp.31-42, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00807801

I. Lartaud, L. Bray-des-boscs, J. Chillon, J. Atkinson, and C. Capdeville-atkinson, In vivo cerebrovascular reactivity in Wistar and Fischer 344 rat strains during aging, Am J Physiol, vol.264, pp.851-858, 1993.

G. Zanini, Y. Martins, P. Cabrales, J. Frangos, and L. Carvalho, S-nitrosoglutathione Prevents Experimental Cerebral Malaria, Journal of Neuroimmune Pharmacology, vol.32, issue.11, pp.477-487, 2012.
DOI : 10.1007/s11481-012-9343-6

N. Sogo, C. Campanella, D. Webb, and I. Megson, S-Nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery, British Journal of Pharmacology, vol.63, issue.suppl II, pp.1236-1244, 2000.
DOI : 10.1038/sj.bjp.0703700

N. Niederhoffer, V. Marque, I. Lartaud-idjouadiene, C. Duvivier, R. Peslin et al., Vasodilators, Aortic Elasticity, and Ventricular End-Systolic Stress in Nonanesthetized, Unrestrained Rats, Hypertension, vol.30, issue.5, pp.1169-1174, 1997.
DOI : 10.1161/01.HYP.30.5.1169

M. Defontis, S. Cote, M. Stirn, and D. Ledieu, Optimization of Multiplate?? whole blood platelet aggregometry in the Beagle dog and Wistar rat for ex vivo drug toxicity testing, Experimental and Toxicologic Pathology, vol.65, issue.5, pp.637-644, 2013.
DOI : 10.1016/j.etp.2012.07.003

C. Kim, J. Yun, I. Bae, Y. Park, Y. Jeong et al., Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100?? and Multiplate?? whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo, Thrombosis Research, vol.127, issue.6, pp.565-570, 2011.
DOI : 10.1016/j.thromres.2011.02.004

A. Shatoor, H. Soliman, F. Hashem, B. Gamal, A. Othman et al., Effect of Hawthorn (Crataegus aronia syn. Azarolus (L)) on Platelet Function in Albino Wistar Rats, Thrombosis Research, vol.130, issue.1, pp.75-80, 2012.
DOI : 10.1016/j.thromres.2012.01.001

F. Niessen, T. Hilger, M. Hoehn, and K. Hossmann, Differences in Clot Preparation Determine Outcome of Recombinant Tissue Plasminogen Activator Treatment in Experimental Thromboembolic Stroke, Stroke, vol.34, issue.8, pp.2019-2024, 2003.
DOI : 10.1161/01.STR.0000080941.73934.30

M. De-ryck, J. Van-reempts, M. Borgers, A. Wauquier, and P. Janssen, Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats, Stroke, vol.20, issue.10, pp.1383-1390, 1989.
DOI : 10.1161/01.STR.20.10.1383

J. Bederson, L. Pitts, M. Tsuji, M. Nishimura, R. Davis et al., Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination, Stroke, vol.17, issue.3, pp.472-476, 1986.
DOI : 10.1161/01.STR.17.3.472

M. Nedelmann, T. Wilhelm-schwenkmezger, B. Alessandri, A. Heimann, F. Schneider et al., Cerebral embolic ischemia in rats: Correlation of stroke severity and functional deficit as important outcome parameter, Brain Research, vol.1130, pp.188-196, 2007.
DOI : 10.1016/j.brainres.2006.10.087

R. Swanson, M. Morton, G. Tsao-wu, R. Savalos, C. Davidson et al., A Semiautomated Method for Measuring Brain Infarct Volume, Journal of Cerebral Blood Flow & Metabolism, vol.16, issue.2, pp.290-293, 1990.
DOI : 10.1038/jcbfm.1990.47

F. Faul, E. Erdfelder, A. Lang, and A. G. Buchner, G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences, Behavior Research Methods, vol.47, issue.2, pp.175-191, 2007.
DOI : 10.3758/BF03193146

M. Khan, M. Jatana, C. Elango, A. Paintlia, A. Singh et al., Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke, Nitric Oxide, vol.15, issue.2, pp.114-124, 2006.
DOI : 10.1016/j.niox.2006.01.008

H. Kranz, G. Brazeau, J. Napaporn, R. Martin, W. Millard et al., Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems, International Journal of Pharmaceutics, vol.212, issue.1, pp.11-18, 2001.
DOI : 10.1016/S0378-5173(00)00568-8

J. Li, F. Chen, C. Hu, L. He, K. Yan et al., Optimized Preparation of in Situ Forming Microparticles for the Parenteral Delivery of Vinpocetine, CHEMICAL & PHARMACEUTICAL BULLETIN, vol.56, issue.6, pp.796-801, 2008.
DOI : 10.1248/cpb.56.796

L. Solorio, B. Babin, R. Patel, J. Mach, N. Azar et al., Noninvasive characterization of in situ forming implants using diagnostic ultrasound, Journal of Controlled Release, vol.143, issue.2, pp.183-190, 2010.
DOI : 10.1016/j.jconrel.2010.01.001

D. Giustarini, A. Milzani, I. Dalle-donne, and R. Rossi, Detection of S-nitrosothiols in biological fluids: A comparison among the most widely applied methodologies, Journal of Chromatography B, vol.851, issue.1-2, pp.124-139, 2007.
DOI : 10.1016/j.jchromb.2006.09.031

E. Bramanti, V. Angeli, Z. Mester, A. Pompella, A. Paolicchi et al., Determination of S-nitrosoglutathione in plasma: Comparison of two methods, Talanta, vol.81, issue.4-5, pp.1295-1299, 2010.
DOI : 10.1016/j.talanta.2010.02.024

J. Yoo, G. Acharya, and C. Lee, In vivo evaluation of vaginal films for mucosal delivery of nitric oxide, Biomaterials, vol.30, issue.23-24, pp.3978-3985, 2009.
DOI : 10.1016/j.biomaterials.2009.04.004

T. Rassaf, L. Poll, P. Brouzos, T. Lauer, M. Totzeck et al., Positive effects of nitric oxide on left ventricular function in humans, European Heart Journal, vol.27, issue.14, pp.1699-1705, 2006.
DOI : 10.1093/eurheartj/ehl096

L. Jia, C. Bonaventura, J. Bonaventura, and J. Stamler, S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control, Nature, vol.380, issue.6571, pp.221-226, 1996.
DOI : 10.1038/380221a0

M. Radomski, D. Rees, A. Dutra, and S. Moncada, S-nitroso-glutathione inhibits platelet activation in vitro and in vivo, British Journal of Pharmacology, vol.44, issue.S1, pp.745-749, 1992.
DOI : 10.1111/j.1476-5381.1992.tb14517.x

G. Zhang, B. Xiang, A. Dong, R. Skoda, A. Daugherty et al., Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation, Blood, vol.118, issue.13, pp.3670-3679, 2011.
DOI : 10.1182/blood-2011-03-341107

W. Kozak, A. Kozak, M. Johnson, H. Elewa, and S. Fagan, Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study, Journal of Pharmacology and Experimental Therapeutics, vol.326, issue.3, pp.773-782, 2008.
DOI : 10.1124/jpet.108.139618

F. Sehba, W. Ding, I. Chereshnev, and J. Bederson, Effects of S-Nitrosoglutathione on Acute Vasoconstriction and Glutamate Release After Subarachnoid Hemorrhage ?? Editorial Comment, Stroke, vol.30, issue.9, pp.1955-1961, 1999.
DOI : 10.1161/01.STR.30.9.1955

C. Geeganage, M. Tracy, T. England, G. Sare, T. Moulin et al., Relationship Between Baseline Blood Pressure Parameters (Including Mean Pressure, Pulse Pressure, and Variability) and Early Outcome After Stroke: Data From the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST), Stroke, vol.42, issue.2, pp.491-493, 2011.
DOI : 10.1161/STROKEAHA.110.596163